The Journal of Experimental Medicine
for flow cytometry > invitrogen
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20090383
The Journal of Experimental Medicine, Vol. 206, No. 11, 2321-2328
The Rockefeller University Press, 0022-1007 $30.00
© Dessein et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2992K)
Right arrow PDF+supp data (3446K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Dessein, A.
Right arrow Articles by Li, Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dessein, A.
Right arrow Articles by Li, Y.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Brief Definitive Report

Variants of CTGF are associated with hepatic fibrosis in Chinese, Sudanese, and Brazilians infected with Schistosomes

Alain Dessein1,2,3, Christophe Chevillard1,2, Violaine Arnaud1,2, Xunya Hou4, Anas Ahmed Hamdoun5, Helia Dessein1,2, Hongbin He4, Suzan A. Abdelmaboud5, Xinsong Luo4, Jun Li4, Arthur Varoquaux1,2, Adil Mergani5, Mohammed Abdelwahed5, Jie Zhou4, Ahmed Monis5, Maira G.R. Pitta1,2, Nagla Gasmelseed5, Sandrine Cabantous1,2, Yaqing Zhao4, Aluizio Prata6, Carlos Brandt7, Nasr Eldin Elwali5, Laurent Argiro1,2, and Yuesheng Li4,8

1 Institut National de la Santé et de la Recherche Médicale, U906, 13385 Marseille, France
2 Université de la Méditerranée, Institut Fédératif de Recherche 88, Assistance Publique, Hôpitaux de Marseille, Faculté de Médecine Timone, 13385 Marseille, Cedex 5, France
3 Assistance Publique, Hôpitaux de Marseille, Centre Hospitalier Universitaire Timone, Laboratoire de Parasitologie-Mycologie, 13005 Marseille, France
4 Hunan Institute of Parasitic Diseases, Yueyang, Hunan 414000, China
5 Institute of Nuclear Medicine, Wad Medani, Gezira, Sudan
6 Faculdade de Medicina do Triangulo Mineiro, Uberaba, 38025-180 Minas Gerais, Brazil
7 Universidade Federal de Pernambuco, Recife, 50670-901 Pernambuco, Brazil
8 Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Queensland 4029, Australia

CORRESPONDENCE Alain Dessein: alain.dessein{at}univmed.fr

Abnormal fibrosis occurs during chronic hepatic inflammations and is the principal cause of death in hepatitis C virus and schistosome infections. Hepatic fibrosis (HF) may develop either slowly or rapidly in schistosome-infected subjects. This depends, in part, on a major genetic control exerted by genes of chromosome 6q23. A gene (connective tissue growth factor [CTGF]) is located in that region that encodes a strongly fibrogenic molecule. We show that the single nucleotide polymorphism (SNP) rs9402373 that lies close to CTGF is associated with severe HF (P = 2 x 10–6; odds ratio [OR] = 2.01; confidence interval of OR [CI] = 1.51–2.7) in two Chinese samples, in Sudanese, and in Brazilians infected with either Schistosoma japonicum or S. mansoni. Furthermore, SNP rs12526196, also located close to CTGF, is independently associated with severe fibrosis (P = 6 x 10–4; OR = 1.94; CI = 1.32–2.82) in the Chinese and Sudanese subjects. Both variants affect nuclear factor binding and may alter gene transcription or transcript stability. The identified variants may be valuable markers for the prediction of disease progression, and identify a critical step in the development of HF that could be a target for chemotherapy.


Abbreviations used: CI, confidence interval of OR; CTGF, connective tissue growth factor; ECMP, extracellular matrix protein; HBV, hepatitis B virus; HF, hepatic fibrosis; OR, odds ratio; SNP, single nucleotide polymorphism.

© 2009 Dessein et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Pro-fibrotic SNPs
Amy Maxmen
J. Exp. Med. 2009 206: 2305. [Full Text] [PDF]





  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS